-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the neurosurgery stereotaxic and functional brain disease team led by Prof.
Zhao Guoguang, dean of Xuanwu Hospital, and Prof.
Shan Yongzhi of the Department of Neurosurgery successfully performed closed-loop reactive neurosurgery on a patient with refractory epilepsy (bilateral temporal lobe epilepsy).
Stimulation System Epilcure™ Registered Clinical Trial for Implant Surgery
.
The operation went smoothly, and all the indicators of the intraoperative stimulator worked normally.
The postoperative reconstruction showed that the electrode position was accurate and the EEG signal was clear
The successful completion of this implantation operation marks the successful enrollment of the first patient in the Epilcure™ State Drug Administration-registered clinical trial led by Xuanwu Hospital
The patient is male, and was diagnosed with bilateral temporal lobe epilepsy after admission.
This type of epilepsy is a relative contraindication to craniotomy, and traditional treatment is not effective in the case of uncontrolled medication
The technology uses artificial intelligence chips implanted in the skull, intracranial electrodes implanted in the brain, and continuous monitoring of EEG rhythms day and night.
Patient Imaging Evaluation
Xuanwu Hospital, as the National Medical Center for Neurological Diseases, under the leadership of Professor Zhao Guoguang, the director of the center, started the research on "brain-computer interface" early in clinical units
.
leave a message here
